However, the use of this medication requires a prolonged initial treatment period of dose-escalation to attenuate the adverse gastrointestinal effects (nausea, vomiting, diarrhea) typically associated with GLP-1R agonists, which still occurred frequently but rarely resulted in discontinuation of treatment
Distribution in the U.S
By using our Peptide Calculator, you can confidently manage your peptide therapy with ease and accuracy
It will still be a crowded market, and as the market matures, only those with pricing power, doctor reach and brand trust will survive.
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
Erythema and depapillation of the tongue were the most common findings, however less common among patients without a history of gastrectomy